Sit Investment Associates’s Clovis Oncology, Inc. CLVS Stock Holding History

Sit Investment Associates’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,925	Closed	-$207K	–	494
2015 Q4	$207K	Hold	5,925	–	–	﹤0.01%	399
2015 Q3	$545K	Hold	5,925	–	–	0.01%	362
2015 Q2	$521K	Hold	5,925	–	–	0.01%	360
2015 Q1	$440K	Sell	5,925 -3,900	-40%	-$275K	0.01%	363
2014 Q4	$550K	Sell	9,825 -825	-8%	-$43.4K	0.01%	348
2014 Q3	$483K	Sell	10,650 -5,400	-34%	-$226K	0.01%	375
2014 Q2	$665K	Hold	16,050	–	–	0.01%	367
2014 Q1	$1.11M	Buy	+16,050	New	+$1.18M	0.02%	336

Other funds holding CLVS

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Sit Investment Associates's CLVS Position: Q1 2016 in Review

Sit Investment Associates sold out of Clovis Oncology, Inc. (CLVS) in Q1 2016, closing a stake of 5,925 shares — an estimated $207K sold.

Sit Investment Associates first reported a position in CLVS in Q1 2014 and held it in 8 quarters. The position peaked at $1.11M in Q1 2014. 135 funds tracked by Wall St. Rank hold CLVS as of Q1 2016.

Sit Investment Associates reported no remaining Clovis Oncology, Inc. position as of Q1 2016 after selling out during the quarter.
Sit Investment Associates sold 5,925 Clovis Oncology, Inc. shares in Q1 2016, an estimated $207K.
Sit Investment Associates first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 8 quarters.
Sit Investment Associates's Clovis Oncology, Inc. position peaked at $1.11M in Q1 2014.
135 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2016.

Based on Sit Investment Associates's 13F filing for Q1 2016, filed 14 Apr 2016.